期刊文献+

M2型肿瘤相关巨噬细胞在上皮性卵巢癌中的检测 被引量:1

Detection of M2-polarized tumor-associated macrophages in human epithelial ovarian cancer
下载PDF
导出
摘要 目的:探讨M2型肿瘤相关巨噬细胞(TAMs)在上皮性卵巢癌组织中的分布,及其与临床病理特征及淋巴管(LV)生成的关系。方法:本研究共纳入74例样本,41例卵巢癌为实验组,18例交界性及15例良性肿瘤为对照组,采用免疫组化方法,用CD68标记巨噬细胞(CD68+)、CD163标记M2型TAMs(CD163+)、D2-40标记LV,了解其在实验组和对照组的分布,及与卵巢癌临床病理特征的关系。结果:卵巢癌组CD68+细胞数、CD163+细胞数、LV数均多于交界性和良性肿瘤组(P<0.01)。CD68+细胞分布于癌巢和癌间质,CD163+细胞和LV主要分布于癌间质,癌间质中三者数量明显多于癌巢(P<0.01)。癌巢和癌间质中CD68+、CD163+细胞数及癌间质LV数与临床分期、组织学分化、病理类型、手术切缘累及淋巴结转移有关(P<0.01)。癌间质LV数与CD68+和CD163+细胞数相关(r=0.759,P<0.01;r=0.888,P<0.01)。结论:卵巢癌组织中TAMs主要为M2型,主要分布于癌间质。其细胞数与肿瘤的临床分期、组织分化、病理类型、手术切缘累及和淋巴结转移有关,提示TAMs可能通过促进淋巴管生成,利于肿瘤的淋巴转移。 Objective:To investigate the distribution of M2-Polarized tumor-associated macrophages(TAMs)in human epithelial ovarian cancer as well as its correlation with clinical pathological features and lymphangiogenesis.Methods:Seventy-four samples were enrolled in this study,including 41 samples of patients diagnosed with ovarian cancer as the experimental group,18 samples with borderline ovarian tumors and 15 samples with benign ovarian tumors as the control group.We used CD68 to mark macrophages and CD163 to mark M2-polarized TAMs as well as D2-40 to mark lymphatic vessels(LV)in immunohistochemistry study,to explore the correlation between macrophages distribution and clinical pathological features in these samples.Result:CD68 positive macrophages were detected in both tumor islets and stroma,while CD163-positive TAMs and LV were mainly distributed in the stroma with relatively lower number detected in tumor islets(P0.01).Numbers for CD68+,CD163+ and D2-40+ cels in ovarian cancer were significantly higher than those in the benign and boradline group(P0.01).The number of CD68+ macrophages,M2-polarized TAMs and LV in tumor islets and stroma were closely related to the clinical stage,histological differentiation,pathological subtypes,the surgical magrin involved and lymph node metastasis.They were all statistically significant different(P0.01).The lymph-vessel number in the tumor stroma was related with that of CD68+ macrophages and CD163+ macrophages(r=0.759,P0.01;r=0.888,P0.01).Conclusion:TAMs in overian cancer are predominantly M2 type,mainly distributed in tumor stroma,which are related with clinical stage,histological differentiation,pathological subtypes,the surgical magrin involved and lymph node metastasis of the tumor.The data indicate that TAMs may advocate LV formation which may assist tumor metastasis.
出处 《现代妇产科进展》 CSCD 北大核心 2011年第11期851-855,共5页 Progress in Obstetrics and Gynecology
关键词 卵巢肿瘤 肿瘤相关巨噬细胞 淋巴管 CD163 Ovarian tumors Tumor associated macrophages Lymphatic vessel CD163
  • 相关文献

参考文献12

  • 1Mantovani A, Sica A. Macrophages, innate immunity and cancer : balance, tolerance, and diversity [J]. Curr Opin Immunol, 2010,22 ( 2 ) : 231-237.
  • 2Solinas G, Germano G, Mantovani A, et al. Tumor-associated macrophages ( TAM ) as major players of the cancer-related inflammation [J]. J Leukoc Biol, 2009,86 ( 5 ) : 1065-1073.
  • 3Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation [ J ]. Nature,2008,454 ( 7203 ) :436-444.
  • 4Mosser DM. The many faces of macrophage activation[ J ]. J Leukoc Biol, 2003,73 ( 2 ) : 209-212.
  • 5Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis [J]. Cell, 2010, 141 ( 1 ) :39-51.
  • 6Hagemann T, Wilson J, Burke F, et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype [J]. J Immunol, 2006,176 ( 8 ) : 5023-5032.
  • 7Pettersen JS, Fuentes-duculan J, Suarez-farinas M, et al. Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated[J]. J Invest Dermatol,2011,131 (6) : 1322-1330.
  • 8Ohri CM, Shikotra A, Green RH,et al. Macrophages within nsclc tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival[ J ]. Eur Respir J ,2009,33 ( 1 ) : 118-126.
  • 9Kurahara H, Shinchi H, Mataki Y, et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer [J]. J Surg Res, 2011,167 ( 2 ) : e211-e219.
  • 10Hasita H, Komohara Y, Okabe H, et al. Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma [ J ]. Cancer Sci, 2010, 101 (8) :1913-1919.

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部